Pharma Aids Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	72.46	63.82	61.19	-6.38	34.76	50.26
Depreciation & Amortization	8.29	6.5	6.92	7.62	7.82	8.25
Other Operating Activities	-0.75	-4.9	-4.82	-6.51	-3.69	-4.8
Change in Accounts Receivable	-12.26	-30.73	1.63	-2.54	6.21	11.85
Change in Inventory	37.98	10.81	-17.47	6.5	-15.18	-27.67
Change in Accounts Payable	0.84	-1.67	3.89	0.24	1.25	-0.26
Change in Other Net Operating Assets	-50.62	-4.07	-28.55	8.33	2.67	-6.22
Operating Cash Flow	55.93	39.76	22.79	7.27	33.85	31.41
Operating Cash Flow Growth	772.10%	74.49%	213.55%	-78.53%	7.77%	-22.82%
Capital Expenditures	-56.83	-57.13	-0.18	-2.21	-4.7	-10.28
Sale of Property, Plant & Equipment	-	0.55	-	-	-	-
Sale (Purchase) of Real Estate	-0.32	-13.53	-	-	-	-
Other Investing Activities	-	-	0.11	0.2	0.37	4.6
Investing Cash Flow	-57.14	-70.12	-0.07	-2.01	-4.33	-5.68
Short-Term Debt Issued	-	16.49	-	0.49	0.68	-
Total Debt Issued	16.49	16.49	-	0.49	0.68	-
Short-Term Debt Repaid	-	-	-0.28	-	-	-4.78
Total Debt Repaid	-	-	-0.28	-	-	-4.78
Net Debt Issued (Repaid)	16.49	16.49	-0.28	0.49	0.68	-4.78
Common Dividends Paid	-7.68	-7.66	-4.83	-15.54	-25.27	-15.05
Financing Cash Flow	8.81	8.83	-5.11	-15.05	-24.59	-19.83
Miscellaneous Cash Flow Adjustments	-0	-	-	0	-	-
Net Cash Flow	7.6	-21.53	17.61	-9.79	4.93	5.89
Free Cash Flow	-0.89	-17.37	22.6	5.06	29.15	21.12
Free Cash Flow Growth	-	-	346.82%	-82.64%	37.97%	-40.81%
Free Cash Flow Margin	-0.19%	-3.97%	5.37%	1.64%	9.02%	7.54%
Free Cash Flow Per Share	-0.29	-5.57	7.25	1.62	9.34	6.77
Cash Interest Paid	2.44	1.75	0.26	0.24	0.24	0.9
Cash Income Tax Paid	26.92	27.15	32.43	23.71	25.15	23.17
Levered Free Cash Flow	20.22	-88.26	5.59	9.86	20.13	17.39
Unlevered Free Cash Flow	21.75	-87.17	5.75	10.01	20.37	17.95
Change in Working Capital	-24.07	-25.66	-40.5	12.54	-5.05	-22.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.